Cortexyme's Series B Round

Cortexyme raised a round of funding on May 31, 2018.

Cortexyme is a private company based in San Francisco, California developing therapeutics for Alzheimer's disease and other degenerative disorders based on the discovery by Stephen Dominy, MD that a s…

Articles about Cortexyme's Series B Round: